Workflow
First Solar(FSLR)
icon
Search documents
Roblox, First Solar, And League Enterprise Are Among Top 10 Large Cap Losers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio? - American International Gr (NYSE:AIG), Astera Labs (NASDAQ:AL
Benzinga· 2026-01-11 17:01
Group 1 - Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) lost 11.57% this week [1] - First Solar, Inc. (NASDAQ:FSLR) fell 14.46% after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $269 to $260 [1] - CoStar Group, Inc. (NASDAQ:CSGP) decreased by 10.68% as multiple analysts lowered their price forecast [1] Group 2 - American International Group, Inc. (NYSE:AIG) decreased 10.05% following the announcement of a leadership transition with CEO Peter Zaffino set to retire by mid-2026; Barclays analyst Alex Scott lowered the price forecast from $88 to $81 [2] Group 3 - NRG Energy, Inc. (NYSE:NRG) slumped 8.93% after appointing Robert J. Gaudette as CEO effective April 30, with President Lawrence Coben stepping down immediately [3] - Las Vegas Sands Corp. (NYSE:LVS) fell 9.57% this week [3] Group 4 - Roblox Corporation (NYSE:RBLX) decreased 9.99% as Super League Enterprise Inc. acquired marketing technology firm Let's Bounce; Wells Fargo analyst Ken Gawrelski lowered the price forecast from $141 to $107 [4] - Astera Labs, Inc. (NASDAQ:ALAB) lost 12.18% this week [4] Group 5 - Johnson Controls International (NYSE:JCI) slumped 9.88%; Barclays analyst Julian Mitchell raised the price forecast from $119 to $125 while maintaining an Equal-Weight rating [5] - HDFC Bank Limited (NYSE:HDB) fell 5.44% this week [5]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Solar, Inc. - FSLR
Prnewswire· 2026-01-09 03:16
Group 1 - Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1] - Jefferies downgraded First Solar from Buy to Hold on January 7, 2026, citing lowered guidance, significant de-bookings, and margin compression throughout 2025 [2] - Following the downgrade, First Solar's stock price decreased by $27.67, or 10.29%, closing at $241.11 per share on January 7, 2026 [2] Group 2 - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering multimillion-dollar damages for victims of securities fraud and corporate misconduct [3]
Jefferies Remains Cautious on First Solar (FSLR), Cuts Target to $260
Yahoo Finance· 2026-01-09 03:00
Core Viewpoint - First Solar, Inc. (NASDAQ:FSLR) is experiencing mixed analyst sentiments, with Jefferies downgrading the stock while Deutsche Bank raises its price target, indicating a divergence in market outlook for the company. Group 1: Stock Performance - The share price of First Solar fell by 7.7% between December 31, 2025, and January 7, 2026, making it one of the Energy Stocks that Lost the Most This Week [1]. Group 2: Analyst Ratings and Price Targets - Jefferies downgraded First Solar from 'Buy' to 'Hold' and reduced its price target from $269 to $260, citing concerns over the company's bookings and management's previous guidance cuts [3]. - Deutsche Bank raised its price target on First Solar from $255 to $300 while maintaining a 'Buy' rating, reflecting a more optimistic outlook compared to Jefferies [4]. Group 3: Market Concerns - Jefferies expressed caution for First Solar in 2026, highlighting expectations that the company will not improve its bookings and that recent price declines in Germany could underwhelm investor expectations [3].
Should You Buy the Dip in First Solar Stock?
Yahoo Finance· 2026-01-08 15:45
Core Viewpoint - First Solar's shares dropped over 10% following a downgrade to "Hold" by Jefferies analyst Julien Dumoulin-Smith, citing concerns over limited visibility into future bookings and reduced policy support due to recent legislative changes [1]. Group 1: Financial Performance and Valuation - First Solar's stock is currently trading at a forward price-earnings (P/E) multiple of 11.54x and has a strong balance sheet with improving free cash flow [3]. - The company's gross margins have deteriorated to approximately 11% in 2025 from 20% the previous year, indicating challenges in maintaining pricing power in a competitive landscape [4]. - The book-to-bill ratio stands at about 0.5x, with recent cancellations from a major BP affiliate highlighting counterparty risks and suggesting weaker demand [5]. Group 2: Market Sentiment and Trends - Despite the recent decline, First Solar shares are still up around 100% compared to their 52-week low [2]. - Historical data shows that First Solar has lost an average of 1.20% in February, which may affect its attractiveness to investors at current levels [6]. - Other Wall Street firms remain bullish on First Solar, indicating a divergence in sentiment compared to Jefferies' cautious stance [8].
First Solar's Easy Value Trade Is Over (Rating Downgrade) (NASDAQ:FSLR)
Seeking Alpha· 2026-01-08 01:40
Core Insights - First Solar (FSLR) stock has increased by 20% since the last analysis and has gained over 90% since a Strong Buy rating was issued in March 2025 [1] Group 1 - The stock price of First Solar has shown significant appreciation, indicating strong market performance [1]
Why First Solar Stock Dimmed by More than 10% Today
Yahoo Finance· 2026-01-07 22:46
Core Viewpoint - First Solar's stock experienced a significant decline of over 10% following a downgrade by an analyst, indicating a lack of confidence in the company's future performance [1]. Group 1: Analyst Downgrade - Jefferies analyst Julian Dumoulin-Smith downgraded First Solar's rating from buy to hold and reduced the price target from $269 to $260 per share [2]. - The downgrade is attributed to concerns over the company's bookings, which have not shown improvement, and management's previous reductions in guidance due to customer project cancellations [3]. Group 2: Industry Challenges - The solar industry is facing ongoing struggles, exacerbated by reduced government support following the passage of the U.S. government's Big, Beautiful Bill, which has limited top-down support for alternative energy solutions [4]. - The trend of debookings at First Solar raises concerns about the sustainability of its business model, particularly in light of economic uncertainties affecting consumer confidence [4]. Group 3: Investment Considerations - Analysts from The Motley Fool Stock Advisor have identified ten stocks they believe are better investment opportunities than First Solar, suggesting caution for potential investors [5][6]. - Historical performance of stocks recommended by The Motley Fool indicates significant potential returns, highlighting the importance of careful stock selection in the current market environment [6][7].
First Solar: Easy Money Is Gone, Trimming My Position, But Not Running Away (NASDAQ:FSLR)
Seeking Alpha· 2026-01-07 18:39
Core Viewpoint - The article presents a bullish outlook on First Solar, Inc. (FSLR), highlighting a significant stock price increase of 87% since the author's contrarian view was published last June, outperforming the S&P 500 index [1]. Company Summary - First Solar, Inc. has shown strong performance in the U.S. solar industry, with its stock gaining 87% over the past months, indicating a positive market sentiment towards the company [1]. Analyst Background - The analyst, Dilantha De Silva, has over 10 years of experience in the investment industry, focusing on equity analysis and investment research, particularly in small-cap stocks that are often overlooked by Wall Street [1]. - Dilantha is a CFA Level III candidate and holds qualifications from the Chartered Institute for Securities and Investment (CISI), showcasing a strong professional background in finance [1]. - His insights have been featured on major financial platforms such as CNBC, Bloomberg, Nasdaq, and Yahoo Finance, indicating a recognized authority in the investment community [1].
Jefferies Downgrades First Solar, Shares Drop 4%
Financial Modeling Prep· 2026-01-07 18:37
Core Viewpoint - Jefferies downgraded First Solar from Buy to Hold and reduced the price target to $260.00 from $269.00, resulting in a more than 4% decline in shares during pre-market trading [1] Group 1: 2026 Outlook and Strategic Concerns - Jefferies expressed caution regarding First Solar's 2026 outlook due to limited booking visibility and emerging strategic questions [2] - Expectations surrounding Section 232 tailwinds may disappoint investors, with potential carve-outs for Germany and other regions that could dilute pricing benefits [2] - Developers are accelerating projects ahead of duties and FEOC considerations, which may impact future pricing [2] Group 2: Manufacturing Challenges and Cash Flow - International manufacturing facilities continue to pose challenges while tariffs remain in effect [3] - Although First Solar is expected to remain free-cash-flow positive, the timeline for significant cash generation is likely too extended to act as a near-term catalyst for the stock [3] - Jefferies sees limited upside from current stock levels due to these factors [3]
华尔街顶级分析师最新评级:惠而浦获上调
Xin Lang Cai Jing· 2026-01-07 16:52
Core Viewpoint - The article summarizes significant analyst rating changes that could impact market trends, highlighting upgrades, downgrades, and new coverage ratings for various companies [1][6]. Upgrades - Barclays upgraded Whirlpool (W) from "Neutral" to "Overweight," raising the target price from $104 to $123, citing accelerated market share growth expected in 2025 and continuation into 2026 [5]. - Oppenheimer upgraded McDonald's (MCD) from "Market Perform" to "Outperform," setting a target price of $355, with a more optimistic outlook for the restaurant sector in 2026 despite a poor performance in 2025 [5]. - Barclays upgraded Lowe's (LOW) from "Neutral" to "Overweight," increasing the target price from $259 to $285, based on an expected improvement in non-essential goods demand due to upcoming tax policy changes [5]. - Piper Sandler upgraded Hershey (HSY) from "Neutral" to "Overweight," raising the target price from $193 to $213, noting lower cocoa costs and the removal of cocoa tariffs, which provide flexibility for reinvestment and growth [5]. - Bank of America upgraded Regeneron Pharmaceuticals (REGN) from "Underperform" to "Buy," significantly raising the target price from $627 to $860, as previous concerns regarding Eylea SD have been addressed [5]. Downgrades - Jefferies downgraded First Solar (FSLR) from "Buy" to "Hold," lowering the target price from $269 to $260 due to limited visibility on orders and emerging strategic issues [10]. - Oppenheimer downgraded Yum Brands (YUM) from "Outperform" to "Market Perform," with no target price set, as the stock's risk-reward profile has become balanced after a 13% increase in 2025 [10]. - Montreal Bank Capital Markets downgraded Union Pacific Railroad (UNP) from "Outperform" to "Market Perform," reducing the target price from $270 to $255, citing high uncertainty regarding regulatory outcomes and weak freight demand [10]. - Piper Sandler downgraded Deckers Outdoor (DECK) from "Neutral" to "Underweight," lowering the target price from $100 to $85, as the company has increased discount promotions on its core brands [10]. - Wells Fargo downgraded Humana (HUM) from "Overweight" to "Neutral," setting a target price of $290, due to uncertainties regarding profit margin targets for 2026 [10]. New Coverage - Argus Research initiated coverage on grocery delivery platform Instacart (CART) with a "Buy" rating and a target price of $52, highlighting revenue growth and recent profitability achievements [11]. - Citigroup initiated coverage on Natera (NTRA) with a "Buy" rating and a target price of $300, citing significant growth potential [11]. - Link Consulting initiated coverage on Galecto (GLTO) with an "Outperform" rating and a target price of $46, noting its acquisition of Damola Therapeutics to advance its oncology pipeline [11]. - Wolfe Research initiated coverage on Apogee Therapeutics (APGE) with a "Market Perform" rating, without a target price, predicting mixed catalysts for the stock in 2026 [11]. - Mizuho Securities initiated coverage on Palvella Therapeutics (PVLA) with an "Outperform" rating and a target price of $205, based on positive clinical trial data for its drug Qtorin [11].